Phansenee S, Angkatavanich T, Rittiluechai K, Intharaburan S. Incidence of Cardiotoxicity Associated with The Use of Pegylated Liposomal Doxorubicin in Gynecologic Malignancies. BSCM [internet]. 2024 Oct. 7 [cited 2026 Aug. 28];63(4):229-33. available from: https://he01.tci-thaijo.org/index.php/CMMJ-MedCMJ/article/view/270006